BlackRock Bolsters Wealth Management Arsenal With SpiderRock Advisors Acquisition, Expanding SMA Solutions
BlackRock Bolsters Wealth Management Arsenal With SpiderRock Advisors Acquisition, Expanding SMA Solutions
BlackRock, Inc. (NYSE:BLK) has agreed to acquire the remaining equity interest in SpiderRock Advisors, or SRA, a provider of customized option overlay strategies in the U.S. wealth market.
贝莱德公司（纽约证券交易所代码：BLK）已同意收购美国财富市场定制期权叠加策略提供商SpiderRock Advisors（SRA）的剩余股权。
Financial terms of the deal were not disclosed. This transaction expands on BlackRock's minority investment in SRA made in 2021.
该交易的财务条款未披露。该交易扩展了贝莱德于2021年对SRA的少数股权投资。
The acquisition will expand BlackRock's offerings in personalized separately managed accounts (SMAs), the company said.
该公司表示，此次收购将扩大贝莱德在个性化独立管理账户（SMA）方面的产品范围。
"We look forward to fully integrating SRA's team and capabilities into our U.S. Wealth Advisory business and to further expanding our offerings in SMA solutions," said Joe DeVico, Co-Head of BlackRock's U.S. Wealth Advisory business.
贝莱德美国财富咨询业务联席主管乔·德维科表示：“我们期待将SRA的团队和能力完全整合到我们的美国财富咨询业务中，并进一步扩大我们在SMA解决方案方面的产品范围。”
As of February 2024, SRA handled around $4.8 billion in client assets. Their SMA strategies prioritize income and risk management, catering to various channels.
截至2024年2月，SRA处理了约48亿美元的客户资产。他们的SMA策略优先考虑收入和风险管理，以满足各种渠道的需求。
The financial impact of the transaction, which is expected to close in the second quarter of 2024, is not material to BlackRock's earnings.
该交易预计将于2024年第二季度完成，其财务影响对贝莱德的收益并不重要。
Last month, the company acquired a minor stake in Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), an artificial intelligence-powered precision cardiovascular medicine company.
上个月，该公司收购了由人工智能驱动的精准心血管医学公司Cardio Diagnostics Holdings Inc.（纳斯达克股票代码：CDIO）的少量股份。
Price Action: BLK shares are trading higher by 0.47% to $835.60 on the last check Friday.
价格走势：在周五的最后一次支票中，BLK股价上涨0.47％，至835.60美元。
Photo: Lukas from Pixabay.
照片：来自 Pixabay 的卢卡斯。